Evidence for TNFα action on excitatory and inhibitory neurotransmission in the central amygdala: A brain site influenced by stress

Brain, Behavior, and Immunity

Volumn 33, Issue , 2013, Pages 102-111

  Ming, Zhen ^a   Criswell, Hugh E ^a   Breese, George R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Central amygdala; CRF receptor antagonists; Glia; MEPSCs; Minocycline; MIPSCs; Neural function; PI 3 kinase antagonist

Indexed keywords

GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; MINOCYCLINE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TETRODOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CELL MEMBRANE; CELL MEMBRANE POTENTIAL; CENTRAL NUCLEUS (AMYGDALA); CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; GLIA; INTRACELLULAR SIGNALING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; STRESS; SYNAPTIC MEMBRANE;

CENTRAL AMYGDALA; CRF-RECEPTOR ANTAGONISTS; GLIA; MEPSCS; MINOCYCLINE; MIPSCS; NEURAL FUNCTION; PI-3-KINASE-ANTAGONIST;

AMYGDALA; ANIMALS; EXCITATORY POSTSYNAPTIC POTENTIALS; INDUCED PLURIPOTENT STEM CELLS; NEURAL INHIBITION; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PHYSIOLOGICAL; SYNAPTIC TRANSMISSION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883776219     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.06.001     Document Type: Article

References (64)

1. Adler M., Geller E., Chen X., Rogers T. Vieing chemokines as a third major system of communication in the brain. AAPS J. 2006, 7:E865-870.
2. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Zastro Von., Beattie M.S., Malenka R.C. Control of synaptic strength by glial TNFα. Science 2002, 295:2282-2285.
3. Behan D.P., Maciejewski D., Chalmers D., De Souza E.B. Corticotropin releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells. Br. Res. 1995, 698:259-264.
4. Belkouch M., Dansereau M.A., Réaux-Le Goazigo A., Van Steeninckel J., Beaudet N., Chraibi A., Melik-Parsadaniantz S., Sarret P. The chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a Gβγ-dependent mechanism. J. Neurosci. 2011, 31:18381-18390.
5. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y., Hirsch E.C. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 1994, 172:151-154.
6. Breese G.R., Knapp D.J., Overstreet D.H. Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A receptor agonist. Neuropsychopharmacology 2004, 29:470-482.
7. Breese G.R., Overstreet D.H., Knapp D.J. Conceptual frameork for the etiology of alcoholism: a "kindling"/stress hypothesis. Psychopharmacology 2005, 178:367-380.
8. Breese G.R., Overstreet D.H., Knapp D.J., Navarro M. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF-1 and benzodiazepine-receptor antagonists and a 5-HT1A receptor antagonist. Neuropsychopharmacology 2005, 30:1662-1669.
9. Breese G.R., Knapp D.J., Overstreet D.H., Navarro M., Wills T.A., Angel R.A. Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior. Neuropsychopharmacology 2008, 33:867-876.
10. Breese G.R., Sinha R., Heilig M. Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacol. Ther. 2011, 129:149-171.
11. Callewaere C., Banisadr G., Desarmènien M.G., Mechighel P., Kitabgi P., Rostène .H., Mèlik Parsadaniantz.S. The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. Proc. Natl. Acad. Sci. 2006, 103:8221-8226.
12. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H.L., McClay J., Mill J., Martin J., Braithaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HT gene. Science 2003, 301:386-389.
13. Churchill L., Rector D.M., Yasuda K., Fix C., Rojas M.J., Yasuda T., Krueger J.M. Tumor necrosis factor alpha: activity dependent expression and promotion of cortical column sleep in rats. Neuroscience 2008, 156:71-80.
14. Collingridge G.L., Isaac J.T.R., Wang Y.T. Receptor trafficking and synaptic plasticity. Nat. Rev. Neurosci. 2004, 5:957-962.
15. De A., Krueger J.M., Simasko S.M. Tumor necrosis factor alpha increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons. Brain Res. 2003, 981:133-142.
16. Dunn A.J., Wang J., Ando T. Effects of cytokines on cerebral neurotransmission: comparison with the effects of stress. Adv. Exp. Med. Biol. 1999, 461:117-127.
17. Emch G.S., Hermann G.E., Rogers R.C. TNFα activates solitary nucleus neurons responsive to a gastric distension. Am. J. Physiol. GS Liver Physiol. 2000, 279:G582-586.
18. Emch G.S., Hermann G.E., Rogers R.C. TNFα induced c-Fos generation in the nucleus of the solitary tract is blocked by NBQX and MK-801. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281:R1394-1400.
19. Fu Y., Neugebauer V. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. J. Neurosci. 2008, 28:3861-3876.
20. Giuliani F., Hader, Yong V. Minocycline attenuates T cell and microglia activity to impair cytokine production in t cell-microglia interaction. J. Leukocyte Biol. 2005, 78:135-143.
21. Gruol D.L., Nelson T.E. Purkinje neuron physiology is altered by the inflammatory factor interleukin-6. Cerebellum 2005, 4:198-205.
22. Hammen C. Stress and depression. Ann. Rev. Clin. Psychol. 2005, 1:293-319.
23. Heine M., Groc L., Frischknecht R., Béïque J.C., Lounis B., Rumbaugh G., Huganir R.L., Cognet L., Choquet D. Surface mobility of post-synaptic AMPAR tunes synaptic transmission. Science 2008, 320:201-205.
24. Hermann G.E., Hebert S.L., Van Meter M.J., Holmes G.M., Rogers R.C. TNFα-p55 receptors: medullary brainstem imuunocytochemical localization in normal and vagus nerve-transected rats. Brain Res. 2004, 1004:156-166.
25. Holmes G.M., Hebert S.L., Rogers R.C., Hermann G.E. Immunocytochemical localization of TNF type 1 and 2 receptors in the rat spinal cord. Brain Res. 2004, 1025:210-219.
26. Huang M.M., Overstreet D.H., Knapp D.J., Angel R., Wills T.A., Navarro M., Rivier J., Vale, Breese G.R. Corticotropin-Releasing Factor (CRF), sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 Receptors: relation to stress-induced sensitization. J. Pharmacol. Exp. Ther. 2010, 332:298-307.
27. Inagaki T.K., Muscatell K.A., Irin M.R., Cole S.W., Eisenberger N.I. Inflammation selectively enhances amygdala activity to socially threatening images. Neuroimage 2012, 59:3222-3226.
28. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of IL1-β. IL-6 and TNFα in regulating synaptic and neuronal activity in superficial spinal cord. J. Neurosci. 2008, 28:5189-5194.
29. Knapp D.J., Whitman B.A., Wills T.A., Angel R.A., Overstreet D.H., Criswell H.E., Ming Z., Breese G.R. Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety. Brain Behav. Immun. 2011, 25:S146-54.
30. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
31. Krueger JM, Rector DM, Churchill L (2007) Sleep and cytokines. In: Sleep medicine clinics of North America: sleep, sleep disorders and hormones (Vgontzas An, ed) pp 161-169.
32. Lindqvist D., Janelidze S., Hagell P., Erhardt S., Samuelsson M., Minthon L., Hansson O., Björkqvist M., Träskman-Bendz L., Brundin L. Interleukin-6 is elevated in CSF of suicide attempters and relate to symptom severity. Biol. Psychiat. 2009, 66:287-292.
33. Lukáts B., Egyed R., Karádi Z. Single neuron activity changes to interleukin-1β in the orbitalfrontal cortex of the rat. Brain Res. 2005, 1038:243-246.
34. Maciejewski D., Croe P.D., De Souza E.B., Behan D.P. Regulation of coricotropin-releasing factor-binding protein expression in cultured rat astrocytes. J. Pharmac. Exp. Ther. 1996, 278:455-461.
35. McAllister J.P., Miller J.M. Minocycline inhibits glial proliferation in the H-Tx rat model of congenital hydrocephalus. Cerebrospinal Fluid Res. 2010, 7:7-8.
36. McClennen S.J., Seasholtz A.F. Transcription regulation of corticotropin-releasing hormone-binding protein gene expression in astrocyte cultures. Endocrinology 1999, 140:4095-4103.
37. Naylor D.E., Liu H., Niquet J., Wasterlain C.G. Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus. Neurobiol. Dis. 2013, 54:225-238.
38. α/βII. J. Biol. Chem. 2007, 282:15208-15216.
39. Nutile-McMenemy N., Elfenbein A., DeLeo J.A. Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression. J. Neurochem. 2007, 103:2035-2046.
40. Oh S.B., Cho C., Miller R.J. Electrophysiological analysis of neural chemokine receptors. Methods 2003, 29:335-344.
41. Porterfield V.M., Zimomra Z.R., Caldell E.A., Camp R.M., Gabella K.M., Johnson J.D. Rat strain differences in restraint stress-induced brain cytokines. Neuroscience 2011, 188:48-54.
42. Prager G., Hadamitzky M., Engler A., Doenlen R., Wirth T., Pacheco-López G., Krügel U., Schedlowski M., Engler H. Amygdaloid signature of peripheral immune activation by bacterial lipopolysaccharide or Staphylococcal enterotoxin B. J Neuroimmune Pharmacol. 2013, 8:42-50.
43. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuro-inflammation and progressive. Glia 2007, 55:453-462.
44. Rainey-Smith S.R., Andersson D.A., Williams R.J., Rattray M. Tumor necrosis factor-α induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurons by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration. J. Neurochem. 2010, 113:692-703.
45. Roberto M., Cruz M.T., Gilpin N., Sabino V., Schweitzer P., Bajo M., Cottone P., Madamba S.G., Stouffer D.G., Zorrilla E.P., Koob G.F., Siggins G.R., Parsons L.H. Corticotopin-releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biol. Psychiat. 2010, 67:831-839.
46. Rostène W., Kitabgi P., Parsadaniantz S.M. Chemokines: a new class of neuromodulator?. Nat. Rev. Neurosci. 2007, 8:895-903.
47. Santello M., Volterra A. TNFα in synaptic function: switching gears. TINS Trends Neurosci. 2012, 35:547-638.
48. Santello M., Bezzi P., Volterra A. TNFα controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron 2011, 69:988-1001.
49. Shin L.M., Liberzon I. The neurocircuitry of fear, stress and anxiety disorders. Neuropsychopharmacology 2010, 35:169-191.
50. Soczynska J.K., Mansur R.B., Brietzke E., Swardfager W., Kennedy S.H., Woldeyohannes H.O., Poell A.M., Manierka M.S., McIntyre R.S. Novel therapeutic targets in depression: minocycline as a candidate treatment. Behav. Brain Res. 2012, 235:302-317.
51. Stellwagen D., Malenka R.C. Synaptic scaling mediated by glial TNF-alpha Nature 2006, 440:1054-1059.
52. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by TNFα. J. Neurosci. 2005, 25:3219-3228.
53. Stück E.D., Christensen R.N., Huie J.R., Tovar C.A., Miller B.A., Knout Y.S., Bresnahan J.C., Beattie M.S., Ferguson A.R. Tumor necrosis factor alpha mediates GABAA receptor trafficking to the plasma membrane of spinal cord neurons in vivo. Neural Plats 2012, Article number-261345.
54. Tabarean I.V., Koran H., Bartram T. Interleukin-1β induces hyper-polarization and modulates synaptic inhibition in preoptic and anterior hypothalamic neurons. Neuroscience 2006, 141:1685-1695.
55. Tian J.B., Bishop G.A. Frequency-dependent expression of corticotopin releasing factor in rat's cerebellum. Neuroscience 2003, 121:363-377.
56. Ubink R., Calza L., Hökfelt T. 'Neuro'-peptides in glia: focus on NPY and galanin. Trends Neurosci. 2003, 26:604-609.
57. Vachon-Presseau E., Martel M.-O., Roy M., Caron E., Albouy G., Marin M.-F., Plante I., Sullivan M.J., Lupien S.J., Rainville P. Acute stress contributes to individual differences in pain and pain-related brain activity in healthy and chronic pain patients. J. Neurosci. 2013, 33:6826-6833.
58. Vitkovic L., Bockaert J., Jacque C. "Inflammatory" cytokines: neuromodulators in normal brain?. J. Neurochem. 2000, 74:457-471.
59. Watkins L.R., Milligan E.D., Maier S.F. Glial activation: a driving force of pathological pain. Trends Neurosci. 2001, 24:450-455.
60. Whitman B, Knapp DJ, Werner DF, Crews FT, Breese GR. (2013a) The Cytokine-mRNA Increase Induced by withdrawal from Chronic Ethanol in the Sterile Environment of Brain is mediated by CRF and HMGB1 Release. Ethanol Clin Exp Res. (in press).
61. Whitman B, Knapp DJ, Zimomra, Z. Breese GR. (2013b). HMGB1-signaling supports stress-induction of cytokine-mRNAs after chronic-alcohol withdrawal, but not induction of cytokine-mRNAs in controls. Brain Behavior and Immunity. (submitted for publication).
62. Wholeb E.S., Hanke M.L., Corona A., Poell N.D., Stiner L.M., Bailey M.T., Nelson R.J., Godbout J.P., Sheridan J.F. β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 2011, 31:6277-6288.
63. Wilkinson M.F., Mathieson B., Pittman Q.J. Interleukin-1β has excitatory effects on neurons of the BNST. Brain Res. 1993, 625:342-346.
64. Yan M., Xia C., Niu S., Cheng C., Shao X., Shen A. The role of TNFα and its receptors in production of β-1,4-galactosyltransferase I mRNA by rat primary type-2 astrocytes. Cell Mol. Neurobiol. 2008, 28:223-236.